BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 4:18:23 PM | Browse: 158 | Download: 737
 |
Received |
|
2024-10-06 15:04 |
|
Peer-Review Started |
|
2024-10-06 15:04 |
|
First Decision by Editorial Office Director |
|
2024-12-26 23:27 |
|
Return for Revision |
|
2024-12-27 01:40 |
|
Revised |
|
2025-01-08 15:50 |
|
Publication Fee Transferred |
|
2025-01-13 12:08 |
|
Second Decision by Editor |
|
2025-01-21 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-01-21 07:56 |
|
Articles in Press |
|
2025-01-21 07:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-03-05 08:30 |
|
Publish the Manuscript Online |
|
2025-03-25 16:18 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing Fei, Li-Wen Qi, Yuan Liu, Min Shu and Wen-Qiang Mo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jing Fei, Department of Oncology, The First Affiliated Hospital of Shihezi University, No. 107 North Second Road, Shihezi 832008, Xinjiang Uygur Autonomous Region, China. feij_xj@163.com |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; Radiofrequency ablation; Survival analysis; Multimodal therapy; Locoregional therapy; Synergistic effects |
| Core Tip |
Our study addresses a critical aspect of hepatocellular carcinoma (HCC) treatment, comparing the outcomes of transarterial chemoembolization (TACE) alone vs the combination of TACE with percutaneous radiofrequency ablation. With a robust retrospective analysis of 106 patients, our findings highlight significant enhancements in treatment efficacy and survival rates when these therapies are combined, thus proposing a pivotal shift in therapeutic strategies for patients with unresectable HCC. |
| Publish Date |
2025-03-25 16:18 |
| Citation |
Fei J, Qi LW, Liu Y, Shu M, Mo WQ. Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment. World J Gastrointest Oncol 2025; 17(4): 102038 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i4/102038.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i4.102038 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
